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ABSTRACT 
 
Results from previous experiments have provided evidence for T-type channel 
expression in adult pulmonary artery smooth muscle cells (PASMCs) using 
electrophysiology and qRT-PCR. Studies have also shown that when T-type channels are 
blocked, either pharmacological or with small hairpin RNA targeted against T-type 
channel Cav3.1 subunit, mRNA levels are reduced and cell proliferation is inhibited. 
These results suggest a connection between T-type calcium channels and cell 
proliferation. In this thesis, Cav3.1 and its possible interplay with cyclin D, an early 
marker of the cell cycle, was investigated. The time course of cyclin D’s translocation to 
the nucleus to begin the cell cycle was studied and once a baseline was established, the T-
type Ca2+ channel was knocked down either using a pharmacological blocker, mibefradil, 
or with shRNA and its effects on the nuclear translocation of cyclin D are presented. Our 
results suggest that a connection exists between Cav3.1 and cyclin D in the initiation of 
the cell cycle. 
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    CHAPTER 1 
BACKGROUND 
 Calcium is a universal second messenger that regulates a number of diverse 
cellular processes including cell proliferation, development, motility, secretion, learning 
and memory. Voltage dependent calcium channels are closed during the membrane 
resting state. Once a cell has become depolarized or excited these channels open and 
allow an influx of calcium into the cell. Once Ca2+ has entered the cell, a plethora of 
downstream events may occur depending on the type of cells these channels are present 
in.  
 While six classes of calcium channels have been identified; P, Q, N, R, T and L, 
there are two main physiological classes of voltage dependent Ca2+ channels, encoded by 
at least 10 different genes designated as high voltage activated channels, (HVA, Cav1 and 
Cav2) and low voltage activated channels (LVA, Cav3) (2). The L-type channels, 
belonging to the HVA family, are found in both excitable and nonexcitable tissue, and 
they play an important role in normal myocardial and vascular smooth muscle 
contractility. Multiple subunits (alpha-1, alpha-2/delta, beta, and gamma) make up the L-
type channels while T-type channels appear to be comprised of a single alpha subunit 
encoded by one of 3 genes; Cav3.1 (α1G), Cav3.2 (α1H), and Cav3.3(α1I).
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 The importance of Ca2+ signaling during the cell cycle has been well established 
in mammalian cells. Calcium may accumulate intracellularly via two main processes; 
cytoplasmic Ca2+ transients are generated by release of Ca2+ from intracellular pools, 
mainly the sarcoplasmic reticulum (SR) or the endoplasmic reticulum (ER), or by entry 
of Ca2+ from the extracellular environment via Ca2+ channels in the plasma membrane. In 
vascular smooth muscle (VSM), a calcium concentration gradient must be maintained for 
proper physiologic processes. When the concentration gradient is perturbed, large 
 concentrations of intracellular Ca2+ have been found to cause vasoconstriction and even 
cell death. A normal physiological increase in intracellular Ca2+, 50nM-2µM, is required 
for the initiation and progression of the cell cycle. Spontaneous Ca2+ oscillations are 
observed in the G0/G1 phase, at the G1/S transition, during S phase, and during the exit 
from mitosis (17). The oscillations seen immediately after cell quiescence have been 
shown to turn on early genes such as cyclins, which are required for the cell to re-enter 
the cell cycle (3). During the G2/M phase of the cell cycle, the Ca2+ is involved in the 
break down of the nuclear envelope and subsequent division of the cell. The regulation of 
intracellular calcium is especially important for cell proliferation and hypertrophy.   For 
example, it has been shown that the depletion of intracellular inositol 1,4, 5-triphosphate-
sensitive  Ca2+ stores by thapsigargin, a pharmacological agent which blocks the calcium 
ATPase on the ER resulting in Ca2+ depletion in the ER, resulted in a halt of cell division 
(19).  
 Once calcium levels are sufficient to turn on the early genes, such as cyclin D1, 
the cell cycle may progress. There is a highly conserved family of serine/threonine cyclin 
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dependent kinases (CDKs) that become activated upon binding to cyclins. Progression of 
the cell cycle is dependent upon relative levels of individual cyclins. Members of the 
cyclin D family are known as G1 phase cyclins and upon binding to CDK4 regulate the 
transition of cells from the G0 phase into the G1 phase.  Cyclin E family members, 
synthesized during late G1 phase, bind to CDK2 and promote the onset of DNA 
replication during the G1/S phase. Finally cyclin B members are known as the M phase  
cyclins and are synthesized during G2. They pair with CDK 1 and their pairing leads to 
the assembly of characteristic M phase components such as the spindle fibers (8, 18). 
 
 Components of the cyclin D family are particularly important for signaling cell 
cycle entry, or the G0/G1 transition (12). Cyclin D1/CDK4 activity is kept in check by 
several distinct regulatory events. One regulatory protein implicated in the calcium 
dependent mechanisms of cyclinD/CDK regulation is calmodulin (CaM). Calmodulin is a 
ubiquitously expressed calcium binding protein that recent studies have shown to play a 
Orford,K, Nature Reviews 
Genetics  2005; 9: 115-128 
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pivotal role in the regulation of cell cycle progression (8). Calmodulin is a 148 amino 
acid long protein composed of four electronegative calcium binding pockets. CaM is able 
to bind the extracellular calcium following their influx through calcium channels as well 
as calcium from the intracellular pools, the endoplasmic and the sarcoplasmic reticulum. 
Once the four pockets are bound with calcium, CaM acts as a signal transducer turning 
electrical signals into biological signals that regulate numerous downstream cascades 
within the cell. Two potential targets for CaM during the initiation of the cell cycle 
include its interaction with Ca2+/CaM-dependent protein kinases (CaMKs) and the 
interaction with calcineurin; however, the manner in which these proteins interact to 
regulate the cell cycle remains unknown (5). Recent studies have implicated CaMKII 
function early in G1 phase as a regulator of cyclin D/cdk4 activation by 
pharmacologically blocking CaMK activity. These studies showed cellular arrest in the 
G0 phase (16). In addition to CaMKII regulation or as an alternative mechanism, cyclin 
D/CDK4 is subjected to growth factor dependent post-translational regulation. Once the 
cyclin D/ CDK complex is assembled it requires phosphorylation by the CDK-activating 
kinase (CAK). Upon phosphorylation by CAK the complex translocates to the nucleus 
where it initiates its primary role, phosphorylating the retinoblastoma protein (Rb) (7). 
Once Rb is phosphorylated by the complex, E2F transcription factors are freed and are 
able to bind to the promoter sequence of the target genes for the progression of the cell 
cycle (4,10). 
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There is still much to elucidate in the regulation of calcium, the cyclinD/CDK4 
complex and their role in the initiation of the cell cycle. Our lab and others have shown 
the effects of mitogenic agents, fetal bovine serum (FBS) and insulin-like growth factor-1 
(IGF-1), both on the proliferation and the expression of T-type Ca2+ channels in a variety 
of cell types (work unpublished).   
Previously it was thought that T-type channels were primarily limited to fetal or 
neonatal cardiac muscle cells; however, T-type Ca2+ currents were reported in one study 
with long standing pressure overload-induced hypertrophy in adult feline heart (15). 
Thus, electrophysiological analysis provided evidence that T-type channels may be re-
expressed in association with cardiac injury. This experiment did not clarify a role for T-
Regulatory cascade of cyclin gene expression, from  www.sigmaaldrich.com 
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type channels in the injury response. More recent experiments have provided data to 
bolster the evidence of T-type channel involvement during injury response (14). Neonatal 
rat ventricular myocytes (NRVM) were isolated and cultured. The cells were allowed 48 
hours quiescence with 0% serum and then 20% serum was introduced for 24 hours. The 
cells that were exposed to the serum displayed evidence of hypertrophy. These cells as 
well as control, 0% serum, were then treated with known pharmacological T-type and L-
type calcium channel blockers, mibefradil and verapamil.  These blockers caused a dose-
dependent reduction in cell hypertrophy, and the inhibitory action of mibefradil alone 
suggested that T-type channels played a role in the cell injury response, since this drug is 
selective for T-type over L-type calcium channels (1). 
 Our laboratory and others have shown a correspondence between the expression 
of T-type Ca2+ channels in neonatal rat ventricular myocytes (NRVM) and vascular 
smooth muscle cells (VSMC) with stages of proliferation, such as after an injury or in 
pathological conditions (2,14). In one study,  NRVM were serum starved, then exposed 
to 7% fetal bovine serum (FBS), which resulted in an approximately 2-fold upregulation 
of Cav3.1 subunit mRNA after 72 hours (Figure 2). Similar NRVM cell cultures were 
also stained with bromodeoxyuridine (BrdU), a marker of cell cycle and DNA synthesis. 
There was a marked increase in the number of cells in the S-phase after serum addition, 
providing evidence that with the addition of serum to the cell medium cells were 
proliferating.    
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 Finally, a recent study has reported developmental intimal thickening of the 
pulmonary artery and the descending aorta, which involves VSMC proliferation and 
cellular migration. An interesting observation was made when VSMC samples were 
treated with kurtoxin, a selective T-type channel blocker that binds with high affinity to 
the alpha 1G, Cav3.1 subunit and modifies the channel by inhibiting the voltage-
dependent gating mechanics. Thymidine [H3 ] incorporation and BrdU staining were 
decreased suggesting that T-type Ca2+ channels are involved in smooth muscle cell 
proliferation (21). To further investigate the theory of T-type channel involvement in 
cellular proliferation an experiment was done by Dr. Florentina Pluteanu in our lab which 
knocked down Cav3.1 using Adv-Cav3.1sh in VSMC. This method blocks the expression 
of the alpha (pore-forming) subunit of the channel and LVA Ca2+ currents. Adv-Cav3.1sh 
treated VSMC samples were collected and analyzed using qRT-PCR to ensure a proper 
knock down of the T-type channels. VSMC cell cultures were also stained with cyclin D1 
antibody to determine cyclin expression and intracellular (nuclear vs. cytoplasmic) 
localization. Preliminary data suggest that in Adv-Cav3.1sh treated cells, cyclin D seems 
to be arrested within the cytoplasm suggesting that T-type channels play a key role in the 
movement and subsequent localization of cyclin D into the nucleus. These studies 
indicate a correlation between Ca2+ influx through T-type channels and the movement of 
cyclin D into the nucleus to initiate the cell cycle. If the direct interaction between 
calcium influx through T-type channels and cyclin D nuclear translocation can be 
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determined, then T-type channels might become a therapeutic target for pathological 
vascular myocyte proliferation and/or migration. 
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CHAPTER 2 
MATERIALS AND METHODS 
PASMC Culture 
Sprague Dawley rats (200-250 g) are anesthetized with xylazine and ketamine; heart and 
lung are removed and kept in cold low calcium physiological saline solution (PSS).  
Intralobular arterioles (3rd and 4th branches) are dissected, cleaned of adventitia and 
enzymatically dissociated in 2 steps: one incubation in 1 mg/ml collagenase (Roche 
Scientific, USA) for 20 min at 37°C (to remove the remaining adventitia and endothelial 
cells) followed by a second step of 2 mg/ml collagenase and 0.5 mg/ml elastase (Roche 
Scientific, USA) for 60 min at 37°C, followed by trituration and centrifugation 5 min at 
1000 rpm. Cells are resuspended in Smooth Muscle Basal Growth Medium (Clonetics 
Corp., USA) and cultured in 35 mm dishes.  After 3-5 days, when spindle cells start to 
appear, the medium is changed to low serum (0.1 %) in order to remove the fibroblast 
contamination. After 3 days, 5% serum is added back.  When the cells reach a 90% 
confluent layer, they are split and prepared for experiments. The purity of the culture is 
tested by smooth muscle α-actin immunostaining.  Rat PASMC are used from passage 4 
to 10.  The cells used for the preliminary data have shown a minimum 90% α-actin-
positive cells.
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FBS studies- PASMCs were plated in 6 well, on 12mm cover slips coated with gelatin, 
or in 100mm plates and allowed to settle for 24 hours in Smooth Muscle Basal Growth 
Medium. Cells were then arrested for 48 to 72hrs in Dulbecco's Modified Eagle Medium 
in order to (Invitrogen) in order to synchronize cells in the G0//G1 phase of the cell cycle. 
After the arrest 10% FBS was added back into the medium. 
IGF-1 studies- PASMCs were plated in 6 well dishes or on 12 mm cover slips coated 
with 0.2% gelatin. Once the cells reached the desired confluency they were arrested for 
48 hours to obtain synchronization. After the 48 hour period 10µM IGF-1 was added to 
DMEM and the cells were incubated until desired time points. 
Mibefradil studies- PASMCs were plated on 12mm cover slips coated with .2% gelatin 
and allowed to settle for 24 hours. Mibefradil (Tocris) was added to the cells at a 
concentration of 10μM and allowed to incubate for 20 minutes. Following the initial 
incubation time treatments were administered.  
Immunostaining 
PASMC grown on cover slips are fixed in 4% paraformaldehyde/PBS for 20 minutes and 
are then incubated in blocking buffer (1% goat serum/PBS/0.1% Triton X-100) for 1 hour 
at room temperature on a rocker. Primary cyclin D1 and cyclin B antibodies (Sigma) are 
added at a 1:100 dilution in blocking buffer and placed on rocker for 1hr. The cyclin E 
primary antibody (Santa Cruz Biotechnology) is diluted at 1:100 with blocking solution. 
Secondary antibodies, Alexafluor series, are obtained from Invitrogen and are used at a 
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1:200 dilution. The samples are left to incubate in the secondary for at least an hour. The 
cell cover slips are then mounted using Prolong Gold with DAPI from Invitrogen.  
Western Blot 
Plasmid vector containing cyclin-GFP fusion protein is used to transfect HEK cells using 
Lipofectamine from Invitrogen. Cells are harvested with lysis buffer from Qiagen and 
equal amounts of protein and run on 12% polyacrylamide gel. The proteins are 
transferred onto nitrocellulose membranes. Blots are blocked with 5% reconstituted 
powdered milk (Carnation) for 1.5 hours. Primary cyclin D1 (Cell Signaling 
Technologies and Sigma), anti-GFP (Sigma), α smooth muscle actin (Sigma), and Lamin 
A/C (Cell Signaling) antibodies are diluted 1:1000 in TBS-T (10mmol/L Tris [pH 8.0], 
150mmol/L NaCl, and 0.05% Tween-20). Primary antibodies are added and incubated on 
a rocker at 4°C overnight. Secondary antibodies were purchased from Pierce and applied 
to samples in a 1:1000 dilution.  After rinsing with TBS-T, immunoblots are processed 
for ECL detection using ECL Western Blotting Analysis system by GE Healthcare.    
Cytoplasmic vs nuclear fractionation was accomplished using NE-PER Nuclear and 
Cytoplasmic Extraction Reagents (Pierce), according to the manufacturer’s protocol. 
qRT-PCR 
Total RNA is isolated from rat pulmonary artery smooth muscle cells using Sidestep 
Lysis Stabilization Buffer from Stratagene. The cDNA is reverse transcribed using iScript 
from Biorad. The samples are subjected to real time PCR in a reaction containing SYBR 
Green Master Mix and gene expression primer assays from SuperArray.  18s ribosomal 
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RNA assay is used as an internal control to normalize for variable RNA concentrations 
(SuperArray). All reactions are conducted on an Applied Biosystems 7300 Real Time 
PCR system according to the manufacturer’s protocol. Relative quantification data are 
generated by the ∆∆Ct method using RQ software (Applied Biosystems). The primers are 
validated for high efficiency (97-100%) and specificity before running the samples.   
CyclinD-GFP fusion protein 
Full length human cyclin D cDNA clone was obtained from Origene. The primer design 
program Oligo was used to design forward and reverse primers to amplify the cyclin D 
coding region, using the cDNA as the template (forward primer: 5’ 
TGCCCAGGAAGAGCCCCAGCC 3’ and reverse primer: 
5’ACGTCGGTGGGTGTGCAAGCC 3’). The designed primers are ordered from 
Integrated DNA Technologies. The human cyclin D coding region is amplified, gel 
purified (Qiagen gel purification kit) and subcloned into a TOPO-TA vector (Invitrogen), 
which is then subcloned upstream and in frame with green fluorescent protein (GFP) into 
the pEGFP-N1 vector (Clontech). The cyclin-GFP fusion is then cloned into pShuttle-
CMV (Stratagene) for adenovirus construction. pShuttle cyclin-GFP construct is 
electroporated into BJ5183 cells expressing adenovirus vector AdEasy (Stratagene) and 
colonies containing the recombinant adenovirus are identified and isolated. The construct 
is then digested with Pac1 (New England Biolabs) and is used for transfection of HEK 
293 host cells to produce the recombinant adenovirus. The fusion was sequenced for 
confirmation.  
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RNA Interference 
siRNA target finder software (Ambion) was used to first identify siRNA target sequences 
for inhibition of  Cav3.1. The most effective target sequence was selected previously by 
validation using psiCHECK™-1 vector/luciferase reporter system (Promega). This target 
sequence was extended to a 29 base pair sequence that was incorporated into a small 
hairpin RNA (shRNA) construct for Cav3.1 inhibition. shRNA-encoding primers 
(Integrated Data Technologies) were cloned into a fluorescent-tagged expression vector 
(pSilencer DsRed express, Clontech). Cav3.1 shRNA adenovirus is then constructed as 
described in Ambion’s Silencer siRNA construction kit. A negative control adenovirus 
was constructed in a similar fashion using scrambled siRNA target sequence. These 
reagents were constructed previously and Cav3.1 knockdown was validated in the Cribbs 
laboratory.    
Time Lapse Fluorescent Microscopy 
 
Nikon Diaphot inverted microscope was used to acquire time lapse images of PASMCs 
infected with Adv-cycD-GFP. PASMCs were plated on 15mm cover slips coated with 
0.2% gelatin and allowed to reach 70% confluency. The cells were then arrested for 48 
hours in serum free DMEM. After the 48hour arrest, DMEM  supplemented with 10% 
FBS  was added to the culture and allowed to incubate for 3 hours until placed in  a 
chamber placed on a stage heater set at 37°C.  Cells were continually bathed with heated 
HAM’s F-12, with L-glutamine (Mediatech) and 10% FBS. Simple PCI image processing 
system was used to acquire the image. 
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     CHAPTER 3 
RESULTS 
Specific Aim 1. Characterize the expression and activation of intracellular cyclin D 
in proliferating vascular smooth muscle cells. 
Validation of culture. In order to validate our cultures as smooth muscle cells, PASMCs 
were plated and fixed on 12mm cover slips. Cultures were immunostained with a 
monoclonal antibody against α smooth muscle actin, which confirmed our cultures were 
comprised of smooth muscle cells (Figure 1). 
 
 
 
 
 
 
 
 
 
Figure 1.  Immunostaining of PASMC cultures for α-Smooth muscle actin.  
Cultured PASMCs passage 6 were fixed with 4% paraformaldehyde/PBS, 
permeabilized with 0.5% Triton X-100 and stained with monoclonal antibody against α-
SM actin at a dilution of 1:5000.  Blue indicates DAPI staining of the nuclei while 
Alexafluor green 488 stain is for α-SM actin. The first panel is DAPI stain alone while 
the second panel is an overlay of smooth muscle actin and DAPI. 
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PASMC proliferation and T-type channels. Previous studies done in our lab by Dr F. 
Pluteanu have shown PASMC cultures proliferate with serum stimulation. PASMCs were 
plated on 12 mm cover slips, arrested, then stimulated with 5% FBS. PASMCs were 
incubated over night at 37˚ C either with serum or with no serum.  Cells were fixed at 24 
hours, permeabilized, and treated with 2N HCl for 15 minutes to denature the DNA and 
expose the epitopes to the BrdU antibody. Cells in the S phase of the cell cycle were 
indicated by immunostaining for BrdU (Figure 2A). To further study the effects of serum 
stimulation on the T-type channel, PASMCs were plated in 6 well dishes, allowed to 
settle for 24 hours, and then arrested for 48 hours to allow for the cells to synchronize.  
5% FBS was then added back to the medium and samples were collected at 24, 48, 72, 
and 96 hours post serum addition. mRNA samples were isolated and probed with T-type 
subunits Cav3.1 and 3.2. mRNA levels of Cav3.2 remain relatively unchanged while 
Cav3.1 level is increased ~4 fold by 96 hours post stimulation (Figure 2B). qRT-PCR 
results indicate a 2-fold increase in Cav3.1 at 48 hours post stimulation (p<.001). Average 
relative quantification of Cav3.1 at time 24 is 1.13±.36 whereas at time 48 RQ value is 
3.49±.49. Cyclin D RQ at 24 hours is 1.26 and at 48 hours it is 2.61 (also measured by 
Dr. Pluteanu, not shown). 
A similar study was performed by Dr Pluteanu using IGF-1 as the mitogenic 
factor. Labeling of the cells with BrdU indicated that IGF-1 stimulated cell proliferation, 
and qRT-PCR results indicated a 2-fold increase in Cav3.1 at 48 hours post stimulation 
(p<.001) (Figure 3A and B).  These data indicate that PASMCs in culture can be  
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stimulated to enter the cell cycle and proliferate and at the same time Cav3.1 mRNA is  
upregulated. Based on these results, subsequent experiments were designed to investigate 
A 
B 
BrdU DAPI Overlay 
Figure 2.  (A) Representative immunostaining of serum stimulated PASMCs for BrdU/S-
phase entry at 24 hours. PASMCs were incubated overnight with BrdU (Invitrogen), 
fixed, permeabilized, treated with 2N HCl to denature DNA and expose epitopes, and 
stained with monoclonal anti-BrdU@488 antibody (1:50) and nuclei counterstained with 
DAPI. Scale bar =10 um.   
(B). T-type calcium channel subunit mRNA levels in PASMC following serum 
stimulation. Cells were plated in 6 well plates, arrested, and stimulated with 5% FBS. 
mRNA samples were isolated and qRT-PCR was carried out for T-type subunits Cav3.1 
and 3.2. mRNA levels of Cav3.2 remain relatively unchanged. Cav3.1 is increased ~4 
fold by 96 hours post stimulation. Cell # ratio is derived from MTT assay. 
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whether the Cav3.1 T-type Ca2+ channel interacts with cyclin D signaling as an early step 
in cell cycle progression.       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  Effects of IGF-1 on cellular proliferation.   
(A) Samples collected 24 hours after stimulation. Representative immunostaining of 
PASMCs were incubated over night with BrdU (Invitrogen), fixed, permeabilized, and 
treated with 2N HCl to denature DNA and expose epitopes. PASMCs were then stained 
with monoclonal anti-BrdU@488 antibody (1:50) and nuclei counterstained with DAPI. 
Scale bar is 10 um.  
(B) Graph represents PASMCs relative mRNA levels of the Cav3.1 and 3.2 T-type 
subunits. BrdU+/DAPI+ was calculated by dividing the number of BrdU positive cells by 
the number of DAPI cells. Quantity given as a percentage.  
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Cyclin D and mitogenic factors. It remains unknown as to the time course of cyclin D 
translocation to the cell nucleus in order for the cell cycle to begin and therefore, studies 
were done to characterize intracellular cyclin D expression in stimulated PASMC 
cultures.  PASMCs were plated on 12 mm cover slips, allowed to settle for 24 hours, and 
then arrested for 48 hours. After the arrest, 10% FBS was added back to the medium. 
Cells were fixed for immunostaining at 0, 4, 8, and 24 hours post stimulation. 
Immunostaining indicated that cyclin D translocation occurs by 8 hours post FBS 
addition. At 8 hours more than 30% of cells within a PASMC population expressed 
cyclin D within the nucleus compared to 10% at 0 hours (Figure 4A), indicating that the 
cells were entering in the cell cycle from the quiescent phase. At 24 hours the percent of 
cells with nuclear cyclin D is similar to time 0, 11.8%, suggesting that the cells have 
progressed through an entire cell cycle. This interpretation is consistent with previous cell 
counts showing a doubling of cell number at 24 hours after serum stimulation (Dr. F. 
Pluteanu, Figure 2). After 4 hours stimulation, cyclin D intensity was relatively weak and 
diffuse throughout the cell, while at 8 hours the signal was more robust and found within 
the nucleus. Although cyclin D appears to be present in the cells at 24 hours, it is not 
significantly expressed within the nucleus (Figure 4B).  
 The same type of experiment was carried out using IGF-1 as the mitogenic factor 
and similar results were obtained. At 8 hours post IGF-1 addition more than 30% of the 
population showed cyclin D nuclear expression. Total cell counts based on DAPI-positive 
nuclei showed that by 24 hours cell counts showed that the number of cells within the  
19 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.  Effect of FBS on cyclin D nuclear localization.  
(A) Graph represents an n=4 studies from different passage numbers 5-9. PASMCs 
were plated on 12mm cover slips, arrested, and stimulated with 10% FBS. Samples 
were fixed and stained with monoclonal antibody against cyclin D (Sigma) at a dilution 
of 1:400 at 0, 4, 8, and 24 hours post stimulation. Secondary antibody was AlexaFluor 
488 and nuclei were stained with DAPI.  
(B) Immunostaining panel on the left represents DAPI stain while right panel is cyclin 
D expression. Photos were taken of different fields and the number of DAPI positive 
cells was counted. For the percentage of cyclin D nuclear expression, the number of 
positive nuclear cyclin D was divided by the total number of DAPI positive cells. SEM 
was found by taking the percentage of nuclear expression/DAPI for each field and 
comparing to average value for all fields. Values- T=0 12.3± 2.3, T=4 15.1± 3.3, T=8 
33± 2.7, T=24 12.8± 2.4. Bottom panel A=T0 B=T4 C=T8 D=T24 hours post FBS 
stimulation. Images were taken at equal intensities and equal exposures. These samples 
were also stained in parallel.  
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population had doubled (Figure 5). Cell count was determined by taking images of 8 
fields on cover slips and counting the number of DAPI+ cells per field (data not shown).    
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 To determine the transcriptional regulation of cyclin D, qRT-PCR was performed 
to examine the expression of cyclin D mRNA following stimulation with IGF-1. For 
Figure 5. Effects of IGF-1 on Cyclin D nuclear localization.  
(A) Graph represents n=4 studies from different passage numbers 5-9. Conditions were 
the same as stated in Figure 4 but cells stimulated with 100ng/µL IGF-1. SEM values- 
T=0 11.9±2.4, T=4 12.1± 1.5, T=8 31.2± 1.1, T=24 14.8±3.0.  
(B) Representative micrographs of nuclear DAPI (blue) and cyclin D fluorescence in 
IGF-1 treated PASMCs at the indicated time points. 
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these experiments, the same samples were used to measure the expression of cyclin D 
mRNA by qRT-PCR that had been previously evaluated for Cav3.1 expression by Dr. F. 
Pluteanu (as shown in Figure 3). Populations were grown in 6 well plates, arrested, 
stimulated, and the mRNA was isolated at 24 and 48 hours post IGF-1 addition. At 24 
hours post IGF-1 treatment there was a slight but insignificant increase in cyclin D 
mRNA levels. By 48 hours, cyclin D levels were increased by ~2.5 fold as compared to 
time 0 (p=.382). As shown in figure 6, IGF-1 increased Cav3.1 mRNA levels by almost 
3.5-fold which is significant (p<.001).  The increase in both Cav3.1 and cyclin D mRNA 
levels may indicate a role for Cav3.1 in the regulation of cyclin D.  
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Figure 6. Effects of IGF-1 on Cav3.1 and Cyclin D mRNA levels. PASMCs were 
grown in 6 well plates, arrested, stimulated with 100 ng/µL of IGF-1, and the mRNA 
was isolated at 24 and 48 hours post IGF-1 addition (Dr Pluteanu) . qRT-PCR was run 
using SYBR green (Fermentas) and probed with Cav3.1 (Super Array) and Cyclin D 
(Super Array). Error bars are standard error of the mean. Cav3.1 24 hrs 
SEM.1.37±.17. Cyclin D 24 hrs SEM 1.31± .24. Cav 3.1 at 48 hrs SEM 3.48 ±.23. 
Cyclin D at 48 SEM 2.63± .9. (p=.38 cyclin D) (***p.<001 Cav3.1) Statistics from 
one way ANOVA. 
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To further explore the time course of cyclin D localization Western blot analysis 
was performed. Cell cultures were collected and fractionated, separating the nuclear 
components from the cytosolic. The samples were collected at time 0, 4, 8, and 24 hours 
post FBS stimulation. Equal amounts of protein were loaded and the blots were probed 
with cyclin D, lamin A/C (nuclear protein) as well as α smooth muscle actin, as a control 
for protein loading. Lamin served as a marker of fractionation purity (Figure 7).  
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Figure 7. Cytosolic vs Nuclear Cyclin D Fractionation.  
N=1 PASMCs passage 8 were grown in 100mm dishes (Falcon). Cultures were 
plated, arrested, and stimulated with 10% FBS. Samples were harvested and 
components were isolated at 0, 4, 8, and 24 post FBS addition as stated by 
manufacture’s protocol (Pierce). Lamin A/C (Cell Signaling) was used as a marker of 
nuclear components at a concentration of 1:1000. α Smooth muscle actin was run as 
the normalization at 1:1000. Cyclin D was used at a concentration of 1:400 and lanes 
were normalized to αSM actin. Densitometry was performed and normalization was 
calculated by dividing the total pixels in each cyclin D lane by the total number of 
pixels in αSM actin. 
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Cyclin D runs at 36kD and is expressed in all lanes while lamin is seen as a doublet at  
67kD and 62kD and actin at 42kD.  Densitometry was performed on the bands and 
normalization was achieved by dividing cyclin D by α smooth muscle actin signal (Figure 
7 graph). The presence of lamin in cytoplasmic lanes indicates that the fractionation was 
not entirely pure. Results do indicate that nuclear cyclin D was increased compared to 
cytoplasmic cyclin D at 24 post FBS stimulation.  
GFP-tagged cyclin D adenovirus reagent. To visualize the intracellular localization of 
cyclin D in PASMCs and its possible regulation by Cav3.1 T-type Ca2+ channels, a cyclin 
D-GFP fusion protein was constructed and incorporated into an adenoviral vector, to 
allow high efficiency expression of cyclin D-GFP in PASMCs.  Figure 8A outlines the 
construction of Adv-cyclin-GFP.   The proper construction of the Adv-cycD-GFP was 
confirmed by Western blot (Figure 8B). Cyclin D positive staining is seen for both cyclin 
D control plasmid (~36kD) and cyclin D-GFP fusion (larger size due to the fusion 
protein), where no plasmid or GFP lane are negative for cyclin D. On the other hand, 
GFP antibody revealed a band in the GFP and fusion lanes, but not cyclin D or no 
plasmid lanes. These gels indicate that the fusion construct led to the production of intact 
cyclin D and GFP proteins.  
 
Specific Aim 2. Determine the relationship between T-type calcium channels and 
cyclin D activation in proliferating vascular smooth muscle cells. 
Cav3.1 Knockdown in PASMC. Once the movement and the time course of nuclear 
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Figure 8.  Construction and validation of Adv-cycD-GFP.  
(A) Schematic of Adv-cycD-GFP construction.  
(B) 60mm dishes of HEK cells were infected with Adv-cycD-GFP and GFP plasmid 
alone to confirm that GFP alone is not found within the nucleus. Photos taken at a 
magnification of 20X. 
(C) Western Blot of Adv-cycD-GFP. 2 gels run with Fusion, Cyclin D, GFP, and 
plasmid. The gel marked cyclin D was blotted with cyclin D primary antibody (1:400) 
while blot GFP was probed with GFP antibody(1:1000). Cyclin D positive staining is 
seen for both cyclin D control plasmid (~36kD) and cyclin D-GFP fusion (larger size 
due to the fusion protein), where no plasmid or GFP lane are negative for cyclin D. On 
the other hand, GFP antibody a band in the GFP and fusion lanes, but not cyclin D or no 
plasmid lanes. 
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localization had been established we sought to determine the relationship between T-type 
calcium channels and cyclin D activation in proliferating vascular smooth muscle cells. 
Our previous studies may suggest some type of partnership based on the evidence 
 provided by the PCR results. As the Cav3.1 mRNA levels increased, so did the levels of 
cyclin D. We hypothesized that calcium influx through the T-type channel may play a 
role in the initiation of cyclin D translocation to the nucleus to initiate the cell cycle. 
 A pharmacological block of Cav3.1 was achieved using mibefradil, a selective T-
type Ca2+ channel blocker at micromolar concentrations. PASMCs were plated on 12 mm 
cover slips, arrested, and treated with 10µM mibefradil. In this study there was a control 
group that was kept in no serum, a group treated with mibefradil alone and no serum, a 
group treated with 10% FBS, and finally a group treated with mibefradil and 10% FBS.  
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Figure 9. Effect of Mibefradil on cyclin D nuclear translocation. 
PASMCs were plated on 12mm cover slips. 4 groups were established: Control (no 
serum), mibefradil (10μM), 10%FBS, and 10%FBS+mibfradil(10μM). The groups 
treated with mibefradil were pretreated for 30 minutes prior to FBS addition. 
PASMCs were carried out to indicated time points fixed, permeabilized, and stained 
with monoclonal antibody against cyclin D at a dilution of 1:400. SEM Values- 
Control T=0 12.3±2.23, mibefradil T=0 12.7± .88, FBS T=0 10.9± 4.256 
FBS+mibefradil T=0 12.7± 2.6 Control T=8 10.4± 3.2,  mibefradil T=8 9.7± 1.24 
FBS T=8 30± .89 FBS+mibefradil T=8 10± 2.328. 
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The groups treated with mibefradil were pretreated with 10μM of the drug for 30 
minutes. Results indicate that mibefradil acted as a potent inhibitor of cyclin D 
translocation (Figure 9). PASMCs in the treatment group with FBS+mibefradil showed 
very few cells with cyclin D nuclear expression. At time 0 ~13% of the cells within the 
population expressed cyclin D intranuclear; after 4 hours the percentage was 12%, and 
finally at 8 hours after treatment, 9.6% of the cells expressed cyclin D within the nucleus. 
This result indicated that treatment with mibefradil was able to block the nuclear 
expression of cyclin D, which was seen at 30% in populations treated with 10% FBS 
alone. To further explore this connection, Adv-Cav3.1sh was used to knockdown the 3.1 
subunit of the T-type channel (previously constructed and validated for Cav3.1 
knockdown by Dr. F. Pluteanu).  In order to confirm that the knockdown was due to the 
Adv-Cav3.1sh and not because of the infection itself, a nonsense virus, “Adv-SCR” 
Average RQs of Cyclin D1 in PASMCs
0
1
2
3
4
5
6
A
vg
. R
Q
t=0
t=8h
t=0 sh
t=8 sh
Figure 10. Effects of IGF-1 on cyclin D mRNA levels at 8 hours when treated with 
Adv-Cav3.1sh.  
Average of the cyclin D RQ’s from 4 passages. RQ values were calculated using 
T=0 Adv-SCR as the calibrator. Error bars are SEM. A one way ANOVA was used 
for statistics (p=.402) 
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(scrambled target sequence), was used as control. qRT-PCR results confirmed that Adv-
Cav3.1sh at 8 hours post IGF-1 stimulation resulted in substantial knockdown of Cav3.1 
(Figure 10) while Adv-SCR had no significant effect on Cav3.1 mRNA level (not shown). 
Cav3.1 Knockdown and Cyclin D localization in PASMC.  Immunostaining was one 
method used to examine the relationship between T-type Ca2+ channels and cyclin D 
localization. PASMCs were plated on cover slips and infected with either Adv-Cav3.1sh 
for the T-type subunit Cav3.1 or with Adv-SCR that served as control. The PASMCs 
were then arrested and stimulated with IGF-1. Cells were fixed at 0, 4, 8, and 24 hours 
post stimulation and stained for cyclin D (Figure 11A).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Effect of Adv-Cav3.1sh on cyclin D nuclear localization.  
(A) Graph represents n=5 studies from different passage numbers 5-7. PASMCs 
infected with Adv-Cav3.1sh for 5 days. Conditions were the same as stated in Figure 4 
but cells stimulated with 100ng/µL IGF-1. SEM Values T=0 9.8± 3.21, T=4 9.9± 1.63, 
T=812.3± .932, T=24 10.2± 1.04.  (B) Representative micrograph of nuclear DAPI 
stain (blue) and Cyclin D fluorescence in at the indicated time points. 
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With Cav3.1 knockdown, cyclin D staining is found predominantly in the cytoplasm 
compared with images from control panels. As evidenced by the qRT-PCR data, Adv-
Cav3.1sh significantly knocks down the T-type subunit 3.1 but since the mRNA 
degradation is time dependent not all mRNA is eradicated from every cell within a 
population at 5 days post infection. Perhaps that is why we still a few cells that express 
cyclin D within the nucleus. It must be noted though that the percentage of nuclear 
localization is greatly reduced compared to control. At time 0 in the control population 12 
% of cells expressed cyclin D within the nucleus compared to 8.2% for the Adv-Cav3.1sh 
treated cells. At 4 hours post IGF-1 stimulation in the control condition 12.6% of the cells 
expressed cyclin D within the nucleus while only 7.8% was seen in the Cav3.1 
knockdown populations. The most striking contrast can be seen in the 8 hour post 
stimulation population, the time at which cyclin D nuclear expression was previously 
shown to be maximal (Figure 5). At 8 hours post IGF-1 treatment in the control samples, 
31% of the cells expressed cyclin D in the nucleus while in the Cav3.1 knockdown 
population, 13.6% expressed cyclin D within the nucleus. This represents greater than a 
50% reduction in the nuclear expression of cyclin D (Figure 11B).  
Using samples from PASMCs previously infected with Adv-Cav3.1sh or Adv-
SCR and stimulated with IGF-1 (F. Pluteanu), we also examined how the cyclin D 
mRNA levels may be affected with Cav3.1 knockdown. Cultures were infected with Adv-
Cav3.1sh for 5 days, arrested, and then stimulated with IGF-1. mRNA was isolated at 8 
and 24 hours after IGF-1 treatment. As seen in figure 10, Adv-Cav3.1sh showed an 
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average RQ value of .25±.145 of the Cav3.1 subunit of the T-type channel. With this 
knockdown, cyclin D mRNA levels at 8 hours were also greatly reduced, 1.3 fold when 
compared to the levels of mRNA in the control (Adv-SCR) population at the same time 
points. Another point to note is that these results are consistent with our evidence of the 
time course of cyclin D nuclear expression. We saw an increase in mRNA levels at time 
8 hours post stimulation which matches our results from the immunostaining studies. 
When the T-type was knocked down using Adv-Cav3.1sh the cyclin D mRNA was 
greatly reduced.  
To further investigate the importance of T-type Ca2+ channel expression in cyclin 
D nuclear translocation, we employed the Adv-cycD-GFP reagent. PASMCs were plated 
on 15 mm cover slips and allowed to attach for 24 hours. The cells were then infected 
with the Adv-cycD-GFP virus. After 24 hours one population of PASMCs was infected 
with Adv-Cav3.1sh, another with Adv-SCR, and one remained only infected with Adv-
cycD-GFP. The Adv-Cav3.1sh and Adv-SCR treated populations were allowed to 
incubate for 5 days to ensure proper knockdown of the Cav3.1 subunit (Adv-SCR for 
control). PASMCs were then arrested for 48 hours. Following the arrest, 10%FBS was 
added back into the media and the cells were placed in the incubator for 3 hours. Cover 
slips were then mounted in a heating chamber and bathed in HAMs F-12 + 10%FBS. 
Time lapse photos were taken every 2 minutes to track the translocation of cyclin D. 
Infection with the Adv- Cav3.1sh and the Adv-SCR were confirmed at the time of serum 
addition by photos taken with red filter to visualize the dsRed portion of the 
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adenoviruses. Nuclear translocation was not observed in our studies under any of the 
conditions. Translocation did occur but the movement was from the nucleus to the 
cytoplasm in every condition (Figure 12, Adv-SCR not shown).  
Figure 12.   Panels of Time Lapse PASMC Adv-cycD-GFP. PASMCs plated on 15 mm cover slips and 
infected with Adv-cycD-GFP for 24 hours. Cultures were arrested for 48 hours and stimulated with 
10% FBS. PASMCs were placed in 37C incubator for 3 hours prior to time lapse. After 3 hour 
incubation cover slips were placed in heating chamber and media was changed to HAMs F-12 with 
10%FBS. Images were acquired every 2 minutes. Adv-cycD-GFP infected PASMCs. Panel is 
composed of images acquired at indicated times. Adv-cycD-GFP + Adv-Cav3.1sh. Panel is composed 
of images acquired at indicated times. 
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CHAPTER 4 
DISCUSSION 
Our experiments set out to determine a relationship between cyclin D and T-type 
calcium channels. Previous studies have provided evidence (Dr Pluteanu, 14) that the 
same factors, for example mitogenic factors, effect the regulation of both the channels 
and cellular proliferation but an association between the two has yet to be established.  
 The first experiments were set up to determine a base line for cyclin D activity, 
namely its translocation to the nucleus to begin the cell cycle. Since data had been 
presented to suggest that T-type channel mRNA is increased with serum and IGF-1, 
studying the effects on cyclin D translocation seemed the logical step. Our results 
confirm the upregulation of the Cav3.1 subunit of the T-type channel as well as confirm 
the mitogenic effects of proliferation on PASMCs. Immunostaining, western blot, and 
qRT-PCR allowed us to determine the time course for cyclin D nuclear expression. While 
results from immunostaining suggest that translocation of cyclin D protein may occur at 8 
hours post stimulation, results from qRT-PCR show an insignificant increase in cyclin D 
mRNA levels at 8 hours. The absence of cyclin D mRNA upregulation at 8 hours may be 
due to the cycling of the cyclin D mRNA itself and the translocation that was observed 
may be do to protein that had been made earlier than the 8 hour time point. Previous 
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studies have suggested a half life of 30 minutes for the cyclin D protein so perhaps the 
mRNA is being made but degraded or perhaps is not stabilized. Further studies where 
PASMC mRNA could be isolated at closer time points after stimulation may prove 
beneficial in better understanding how cyclin D mRNA levels relate to protein expression 
and movement. Since variability was seen within the populations isolated, more 
experiments should be done. 
 Western blot analysis was performed in where the cells underwent fractionation 
of the cytosolic and nuclear fractions. The western seems to confirm our time course of 
translocation for 0, 4, and 24 hours after stimulation but at 8 hours cyclin D appears to be 
more cytosolic when nuclear translocation was expected to be observed based on our 
previous data. Based on the lamin lanes, it should be noted that fractionation was not pure 
which may have lead to the results obtained. This experiment was performed only once 
so more westerns would need to be run in order to reach a conclusion. Due to the 
variability observed in many of our studies cell sorting by FACS analysis may be a useful 
technique in order to better elucidate the time course of cyclin D translocation. A western 
blot looking at the protein levels of Cav3.1 was unable to be performed do to the lack of 
specificity of our Cav3.1 antibody. 
 Once our theory of base line cyclin D activity had been established we set out to 
better understand the interplay between the T-type channel and cyclin D translocation 
when the channel was knocked down. Previous studies have shown the effectiveness of 
mibefradil, a pharmacological T-type channel blocker, on the channel so studies were 
performed to corroborate this data as well examine the knockdown of the T-type channels 
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effects on cyclin D. Immunostaining results suggest that mibefradil was able to block the 
T-type channel do to the low percentage of cells with cyclin D nuclear expression after 
treatment. For the immunostaining experiments, cell populations received 10 µM of 
mibefradil which was suitable to block the T-type channel based on electrophysiology 
findings performed by Dr F. Pluteanu (data not shown). While the nuclear expression of 
cyclin D seemed to be blocked with this knockdown, it should be stated that cells did not 
survive past 24 hours of treatment with mibefradil. To further confirm our data, qRT-
PCR should be done to confirm that the Cav3.1 channel was knocked down while the L-
type channel was unaffected.  
 Since the specificity of pharmacological agents for T-type channels is low, small 
hairpin RNAs were designed in our lab to directly target the mRNA of Cav3.1 and silence 
the gene. Immunostaining results indicated interplay with cyclin D and the T-type 
channel based on the data that the percentage of cells with nuclear expression of cyclin D 
was greatly reduced at every time point with treatment with Adv-Cav3.1sh. Our qRT-
PCR results also show a slight reduction in cyclin D mRNA levels, specifically at 8 hours 
post stimulation but were not significant (Figure 10). mRNA levels of cyclin D as well as 
Cav3.1 were unaffectedby the nonsense virus, Scramble, used as control (Figure 10). 
 In order to visualize the movement of cyclin D within PASMCs, cyclin D was 
fused to a GFP and inserted into an adenovirus. It should be noted that with this construct 
over expression of exogenous cyclin D is observed and may behave differently than 
endogenous cyclin D. After the Adv-cycD-GFP was made, HEK cells were infected 
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either with GFP alone or with Adv-cycD-GFP, which was found in the nucleus. Based on 
this result, time lapse experiments were set up and PASMCs were infected with; Adv-
cycD-GFP, Adv-cycD-GFP plus Adv-Cav3.1sh, or Adv-cycD-GFP plus Adv-SCR. There 
were many limitations for these experiments including that the cells could only be placed 
in the heated chamber for 2 hours before dying. The time lapse experiment was 
performed twice and more studies must be done in order to gain a better understanding of 
the effects of Adv-Cav3.1sh on the translocation of cyclin D. 
 The scope of this thesis was limited to the study of cyclin D because it is one of 
the earliest players in the cell cycle but future experiments may want to look at down 
stream proteins such as other cyclins or CDKs and their possible involvement with the T-
type channel. Serum stimulation and IGF-1 were the only mechanisms of proliferation 
studied so the scope of mitogenic factors that influence the interaction between the T-
type channel and cyclin D translocation could be broadened.  
The T-type channel is comprised of 3 subunits, only 2 of which were studied in 
this paper. Mibefradil targets the Cav3.1 and 3.2 subunits displaying preference for 
Cav3.1 but using pharmacological blockers is not the best option for blocking these 
channels since the drug has a propensity to also block L-type channels. qRT-PCR data 
confirms the knockdown of the Cav3.1 mRNA using Adv-Cav3.1sh (Figure 10) which 
suggested the involvement of T-type channel with cyclin D regulation but the Cav3.2 
subunit was not directly addressed. Previous studies performed by Dr Pluteanu showed 
that serum and mitogenic factors do not seem to have a direct effect the Cav3.2 subunit 
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(Figure 2B) and hence were not directly studied in this thesis project. While the data 
presented suggest a correlation between the T-type and cyclin D regulation many other 
players are yet to be studied. The role of calmodulin and calcineurin could be looked at as 
possible intracellular calcium messengers and their interaction with cyclin D or if a 
relationship exists with the T-type channel. As previously stated cyclin D is an earlier 
player in the cell cycle but even cyclin D is a down stream target of many pathways 
including the MAPK/ERK and PI3 pathways (20). Studying players in this pathway may 
serve as a mechanism to better understand smooth muscle proliferation.
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CHAPTER 5 
CONCLUSIONS 
 
 From the studies preformed in this thesis a few conclusions may be drawn. The 
evidence provides a theory that T-type calcium channels are involved in the activation 
but not the transcriptional regulation of cyclin D. Meaning that the channels may be 
involved in the movement and subsequent activation of the cyclin D protein itself and not 
in its transcriptional regulation. qRT-PCR studies provided little evidence of a direct 
correlation between T-type channel upregulation and the upregulation of cyclin D mRNA 
levels. There may be a trend but more studies are required to elucidate a connection. The 
experiments that make the case for this conclusion are the mibefradil studies as well as 
the immunostaining studies performed when cultures were infected with Adv-Cav3.1sh. 
Results from both of these studies indicate that the T-type channel is needed for the 
nuclear expression of cyclin D, indicating that the channel allows the cyclin D protein to 
translocate into the nucleus. The mibefradil as well as the Adv-Cav3.1sh studies show a 
marked reduction in nuclear expression of cyclin D post stimulation, specifically at 8 
hours.  More studies may be necessary to determine the exact relationship between the T-
type channel and cyclin D such as western blot analysis examining the expression of 
cyclin D within the nucleus following the knockdown of the T-type channel.   
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CHAPTER 6 
FUTURE STUDIES 
 Future studies to perform would be cell sorting by FACS which would allow us to 
determine just how many cells in a population are undergoing which specific stage of the 
cell cycle. Also other mitogenic factors should be examined for their effect on both the T-
type channel and cyclin D, for example thyroid hormone (T3) which has been shown to 
induce cyclin D nuclear translocation (11). Future experiments should also start to look at 
how some of the down stream players are affected under the same experimental 
conditions performed in this thesis such as cyclin E and A, which are cyclins required for 
the transition between G1/S phase and G2/M phases respectively. In order to clarify how 
cyclin D mRNA levels affect protein expression, mRNA should be isolated at closer time 
intervals. Finally, performing cytosolic vs. nuclear fraction western blots with 
populations infected with Adv-Cav3.1sh and Adv-SCR would help clarify the role of the 
T-type channels’ involvement with cyclin D nuclear translocation.
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